Hsiu Kim, Lina Lim

Lim Hsiu Kim, Lina

  • Associate Professor, Department of Physiology
Administrative Appointment(s)
  • Fellow, Tembusu College, National University of Singapore
Academic Qualifications
  • PhD, University of London, United Kingdom
  • BSc, King's College London, University of London, United Kingdom
Research Interest(s)
  • Innate Immunity
  • Macrophages
  • Dendritic Cells
  • Influenza
  • Breast Cancer
Recent Publications
  • 1. Wang C, Kar S, Lai X, Cai W, Arfuso F, Sethi G, Lobie PE, Goh BC, Lim LHK, Hartman M et al. 2018 Jan. Triple negative breast cancer in Asia: An insider's view. Cancer Treatment Reviews. 62:29-38. doi: 10.1016/j.ctrv.2017.10.014.
  • 2. Moraes LA, Kar S, Foo SL, Gu T, Toh YQ, Ampomah PB, Sachaphibulkij K, Yap G, Zharkova O, Lukman HM et al. 2017 Dec. Annexin-A1 enhances breast cancer growth and migration by promoting alternative macrophage polarization in the tumour microenvironment. Scientific Reports. 7:17925. doi: 10.1038/s41598-017-17622-5.
  • 3. Alli-Shaik A, Wee S, Lim LHK, Gunaratne J. 2017 Dec. Phosphoproteomics reveals network rewiring to a pro-adhesion state in annexin-1-deficient mammary epithelial cells. Breast Cancer Research. 19:132. doi: 10.1186/s13058-017-0924-4.
  • 4. Ampomah PB, Moraes LA, Lukman HM, Lim LHK. 2017 Nov. Formyl peptide receptor 2 is regulated by RNA mimics and viruses through an IFN-╬▓-STAT3-dependent pathway. FASEB. doi: 10.1096/fj.201700584RR.
  • 5. Chen L, Yuan Y, Kar S, Kanchi MM, Arora S, Kim JE, Koh PF, Yousef E, Samy RP, Shanmugam MK et al. 2017 Nov. PPAR╬│ Ligand-induced Annexin A1 Expression Determines Chemotherapy Response via Deubiquitination of Death Domain Kinase RIP in Triple-negative Breast Cancers. Mol Cancer Ther. 16(11):2528-2542. doi: 10.1158/1535-7163.MCT-16-0739.